Literature DB >> 19238588

Symptomatic venous thromboembolism: incidence and risk factors in patients with spontaneous or traumatic intracranial hemorrhage.

Keri S Kim1, Gretchen M Brophy.   

Abstract

OBJECTIVES: The objectives of this study are to determine the incidence of symptomatic venous thromboembolism (VTE) in neurosurgery intensive care unit (NSICU) patients with spontaneous or traumatic intracranial hemorrhage and to identify the common VTE risk factors by injury type.
METHODS: This retrospective, single-center cohort study included adult patients admitted to the NSICU between January 2001 and July 2004 with a primary diagnosis of subarachnoid hemorrhage (SAH), intracerebral hemorrhage (ICH), or traumatic brain injury (TBI). Patients and VTE events were identified using ICD-9 codes. All patients received low-dose unfractionated heparin or enoxaparin and intermittent pneumatic compression device. Descriptive statistics were used to describe patient characteristics.
RESULTS: The overall incidence of symptomatic VTE was 3.8% (n = 1195). The incidence of VTE was 6.7% in SAH patients (n = 179), 2.9% in ICH patients (n = 516), and 3.8% in TBI patients (n = 500). The most commonly identified risk factors in the three groups were: greater than 40 years of age, immobility due to paresis or restrictions for mechanical ventilation, presumed infection, and presence of indwelling central venous catheter. There was no objective evidence of intracranial bleeding associated with pharmacologic VTE prophylaxis in VTE patients.
CONCLUSION: This is the first study to determine symptomatic VTE incidence and to identify common risk factors by injury type in nontumor patients who are not routinely screened with venous duplex ultrasonography but receiving early IPC and LDUH. Further studies are needed to determine the overall incident of symptomatic and nonsymptomatic VTE and independent risk factors for VTE events in NSICU patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19238588     DOI: 10.1007/s12028-009-9201-4

Source DB:  PubMed          Journal:  Neurocrit Care        ISSN: 1541-6933            Impact factor:   3.210


  19 in total

1.  Attitudes to the use of prophylaxis for thrombo-embolism in neurosurgical patients.

Authors:  Kanna K Gnanalingham; Jeremy P Holland
Journal:  J Clin Neurosci       Date:  2003-07       Impact factor: 1.961

2.  Guidelines for the management of severe traumatic brain injury. V. Deep vein thrombosis prophylaxis.

Authors:  Susan L Bratton; Randall M Chestnut; Jamshid Ghajar; Flora F McConnell Hammond; Odette A Harris; Roger Hartl; Geoffrey T Manley; Andrew Nemecek; David W Newell; Guy Rosenthal; Joost Schouten; Lori Shutter; Shelly D Timmons; Jamie S Ullman; Walter Videtta; Jack E Wilberger; David W Wright
Journal:  J Neurotrauma       Date:  2007       Impact factor: 5.269

3.  Low molecular weight heparin and compression stockings in the prevention of venous thromboembolism in neurosurgery.

Authors:  M T Nurmohamed; A M van Riel; C M Henkens; M M Koopman; G T Que; P d'Azemar; H R Büller; J W ten Cate; J A Hoek; J van der Meer; C van der Heul; A G Turpie; S Haley; A Sicurella; M Gent
Journal:  Thromb Haemost       Date:  1996-02       Impact factor: 5.249

Review 4.  Venous thromboembolism in neurosurgery and neurology patients: a review.

Authors:  M G Hamilton; R D Hull; G F Pineo
Journal:  Neurosurgery       Date:  1994-02       Impact factor: 4.654

5.  Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

Authors:  William H Geerts; David Bergqvist; Graham F Pineo; John A Heit; Charles M Samama; Michael R Lassen; Clifford W Colwell
Journal:  Chest       Date:  2008-06       Impact factor: 9.410

6.  Complications of subcutaneous low-dose heparin therapy in neurosurgical patients.

Authors:  D Y Wen; W A Hall
Journal:  Surg Neurol       Date:  1998-12

7.  Randomized, pilot study of intermittent pneumatic compression devices plus dalteparin versus intermittent pneumatic compression devices plus heparin for prevention of venous thromboembolism in patients undergoing craniotomy.

Authors:  R Loch Macdonald; Chris Amidei; Joseph Baron; Bryce Weir; Frederick Brown; Robert K Erickson; Javad Hekmatpanah; David Frim
Journal:  Surg Neurol       Date:  2003-05

8.  Deep vein thrombosis: prevalence and risk factors in rehabilitation admissions with brain injury.

Authors:  S A Yablon; W A Rock; T G Nick; M Sherer; C M McGrath; K H Goodson
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

9.  Doppler ultrasonography screening of poor-grade subarachnoid hemorrhage patients increases the diagnosis of deep venous thrombosis.

Authors:  William J Mack; Andrew F Ducruet; Zachary L Hickman; James T Kalyvas; Justin R Cleveland; J Mocco; Michael Schmidt; Stephan A Mayer; E Sander Connolly
Journal:  Neurol Res       Date:  2008-11       Impact factor: 2.448

10.  Risk of postoperative hemorrhage after intracranial surgery after early nadroparin administration: results of a prospective study.

Authors:  Rüdiger Gerlach; Timm Scheuer; Jürgen Beck; Alina Woszczyk; Volker Seifert; Andreas Raabe
Journal:  Neurosurgery       Date:  2003-11       Impact factor: 4.654

View more
  17 in total

1.  Risk factors associated with peripherally inserted central venous catheter-related large vein thrombosis in neurological intensive care patients.

Authors:  Thomas J Wilson; Devin L Brown; William J Meurer; William R Stetler; D Andrew Wilkinson; Jeffrey J Fletcher
Journal:  Intensive Care Med       Date:  2011-11-24       Impact factor: 17.440

2.  Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Michael K Gould; David A Garcia; Sherry M Wren; Paul J Karanicolas; Juan I Arcelus; John A Heit; Charles M Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Venous Thromboembolism After Intraventricular Hemorrhage: Results From the CLEAR III Trial.

Authors: 
Journal:  Neurosurgery       Date:  2019-03-01       Impact factor: 4.654

4.  High dose subcutaneous unfractionated heparin for prevention of venous thromboembolism in overweight neurocritical care patients.

Authors:  Sophie Samuel; Emitseilu K Iluonakhamhe; Eileen Adair; Natalie Macdonald; Kiwon Lee; Teresa A Allison; Huimahn A Choi
Journal:  J Thromb Thrombolysis       Date:  2015-10       Impact factor: 2.300

Review 5.  Update on the Treatment of Spontaneous Intraparenchymal Hemorrhage: Medical and Interventional Management.

Authors:  Thomas J Cusack; J Ricardo Carhuapoma; Wendy C Ziai
Journal:  Curr Treat Options Neurol       Date:  2018-02-03       Impact factor: 3.598

Review 6.  A Systematic Review of the Benefits and Risks of Anticoagulation Following Traumatic Brain Injury.

Authors:  Xian Shen; Sarah K Dutcher; Jacqueline Palmer; Xinggang Liu; Zippora Kiptanui; Bilal Khokhar; Mohammad H Al-Jawadi; Yue Zhu; Ilene H Zuckerman
Journal:  J Head Trauma Rehabil       Date:  2015 Jul-Aug       Impact factor: 2.710

Review 7.  Prophylaxis of Venous Thrombosis in Neurocritical Care Patients: An Evidence-Based Guideline: A Statement for Healthcare Professionals from the Neurocritical Care Society.

Authors:  Paul Nyquist; Cynthia Bautista; Draga Jichici; Joseph Burns; Sanjeev Chhangani; Michele DeFilippis; Fernando D Goldenberg; Keri Kim; Xi Liu-DeRyke; William Mack; Kim Meyer
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

Review 8.  [Aneurysmal subarachnoid hemorrhage].

Authors:  P Kellner; D Stoevesandt; J Soukup; M Bucher; C Raspé
Journal:  Anaesthesist       Date:  2012-09       Impact factor: 1.041

9.  Safety and Efficacy of Warfarin Reversal with Four-Factor Prothrombin Complex Concentrate for Subtherapeutic INR in Intracerebral Hemorrhage.

Authors:  Ryan M Rivosecchi; Joseph Durkin; David O Okonkwo; Bradley J Molyneaux
Journal:  Neurocrit Care       Date:  2016-12       Impact factor: 3.210

10.  Prevention of venous thrombotic events in brain injury: review of current practices.

Authors:  Stuart Glassner; Karan Srivastava; Paul Cofnas; Brian Deegan; Peter Demaria; Rimsky Denis; Enrique Ginzburg
Journal:  Rambam Maimonides Med J       Date:  2013-01-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.